By ICN GroupChemical, March 22, 2020

Govt. approves Rs. 3,820 Cr for medical devices

The union cabinet has approved Rs. 3,820 crores for medical devices manufacturing and production linked incentive scheme

The union cabinet has approved Rs. 3,820 crores for medical devices manufacturing and production linked incentive scheme. 
 
The scheme on promotion of medical device parks for financing common infrastructure facilities in four medical device parks with financial implications of Rs. 400 crores and Production Linked Incentive (PLI) Scheme for promoting domestic manufacturing of medical devices with financial implications of Rs. 3,420 crores. The expenditure to be incurred for the above schemes will be for the next five years i.e. from FY2020-21 to FY2024-25.
 
India depends on imports up to an extent of 85% of total domestic demand of medical devices.The scheme aims to promote medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs.100 crore per park will be provided to the states.
 
The medical device sector suffers from a cost of manufacturing disability of around 12% to 15%, vis-a-vis competing economies, among other things, on account of lack of adequate infrastructure, domestic supply chain and logistics, high cost of finance, inadequate availability of quality power, limited design capabilities and low focus on R&D and skill development, etc. 
 
Under the scheme, incentive at the rate5% of incremental sales over base year 2019-20 will be provided on the segments of medical devices identified under the scheme.
 
The Scheme for Promotion of Medical Device Parks will be implemented by a State Implementing Agency (SIA). The PLI Scheme for promoting domestic manufacturing will be implemented by a Project Management Agency to be nominated by Department of Pharmaceuticals. 
 
The PLI Scheme for promoting domestic manufacturing of medical devices would boost domestic manufacturing and attract large investments in the medical device sector, particularly in the identified target segments. It will lead to expected incremental production of Rs. 68,437 crore over a period of five years. The schemes will lead to generation of additional employment of 33,750 jobs over a period of five years.

OTHER Chemical

View All

McDermott announces early first gas on ONGC's subsea project in India

The company today announced that early first gas has been achieved on India's Oil and Natural Gas Corporation's (ONGC) 98/2 Block in the Krishna Godavari Basin, offshore India

GSFC to start manufacturing from April 4

Ammonia-IV plant will begin its start-up activities from 4th April, 2020 and the plant will run at 55% load

Himadri Speciality Chemical closes manufacturing

The situation will be reviewed and appropriate decisions will be taken as per the evolving situation and in accordance with the directives of the central/state governments